Dietary Quality and Chemotherapy-induced Peripheral Neuropathy in Colon Cancer

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2024 Oct 6

PMID 39369275

Authors

Stephanie L E Compton

Shengping Yang

Joseph Madere

Erin K Weltzien

Bette J Caan

Jeffrey A Meyerhardt

Kathryn H Schmitz

Justin C Brown

Affiliations

Soon will be listed here.

Abstract

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and dose-limiting chemotoxicity caused by oxaliplatin. This study investigated the relationship between dietary quality and the development of moderate and/or severe CIPN in colon cancer survivors using data from the Focus on Reducing Dose-Limiting Toxicities in Colon Cancer with Resistance Exercise trial (ClinicalTrials.gov identifier NCT03291951).

Methods: Diet quality was collected using a 127-item food-frequency questionnaire and was scored using the Alternative Healthy Eating Index-2010 (AHEI-2010). CIPN was assessed with the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events at each chemotherapy cycle. The association of dietary quality with time to the first moderate-to-severe (moderate-severe) or severe event of CIPN was estimated using Cox proportional hazards models. Only participants who received oxaliplatin were included in this analysis (n = 132).

Results: Seventy-four participants (56.1%) reported moderate-severe CIPN. Higher dietary quality was associated with a significantly decreased risk of moderate-severe CIPN (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.93-0.99) and severe CIPN (HR, 0.91; 95% CI, 0.85-0.98). Consumption of red and processed meat (HR, 1.78; 95% CI, 1.07-2.83) and sugar-sweetened beverages (HR, 1.33; 95% CI, 1.10-1.59) was associated with an increased risk of moderate-severe CIPN. Consumption of sugar-sweetened beverages also was associated with an increased risk of severe CIPN (HR, 1.57; 95% CI, 1.14-2.18), whereas vegetable consumption was associated with a reduced risk of severe CIPN (HR, 0.29; 95% CI, 0.09-0.73).

Conclusions: Among patients with colon cancer who received oxaliplatin-based chemotherapy, higher baseline dietary quality was associated with a reduced risk of moderate-severe CIPN.

References

Areti A, Yerra V, Naidu V, Kumar A . Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol. 2014; 2:289-95. PMC: 3909836. DOI: 10.1016/j.redox.2014.01.006. View

Benson A, Venook A, Al-Hawary M, Cederquist L, Chen Y, Ciombor K . NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018; 16(4):359-369. PMC: 10184502. DOI: 10.6004/jnccn.2018.0021. View

Zhou M, Thompson T, Lin H, Chen V, Karlitz J, Fontham E . Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients. Clin Colorectal Cancer. 2021; 21(2):e62-e75. PMC: 8971135. DOI: 10.1016/j.clcc.2021.09.008. View

Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P . Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702. J Clin Oncol. 2022; 41(5):1079-1091. PMC: 9928634. DOI: 10.1200/JCO.22.01637. View

Ford K, Trottier C, Wismer W, Sawyer M, Siervo M, Deutz N . Drivers of Dietary Choice After a Diagnosis of Colorectal Cancer: A Qualitative Study. J Acad Nutr Diet. 2022; 123(3):407-416. DOI: 10.1016/j.jand.2022.08.128. View

Willett W, Howe G, Kushi L . Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997; 65(4 Suppl):1220S-1228S; discussion 1229S-1231S. DOI: 10.1093/ajcn/65.4.1220S. View

Gewandter J, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C . Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013; 21(7):2059-66. PMC: 3669650. DOI: 10.1007/s00520-013-1766-y. View

Ligibel J, Bohlke K, May A, Clinton S, Demark-Wahnefried W, Gilchrist S . Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline. J Clin Oncol. 2022; 40(22):2491-2507. DOI: 10.1200/JCO.22.00687. View

Imamura F, OConnor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju S . Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015; 351:h3576. PMC: 4510779. DOI: 10.1136/bmj.h3576. View

10.

Park S, Goldstein D, Lin C, Krishnan A, Friedlander M, Kiernan M . Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol. 2009; 27(8):1243-9. DOI: 10.1200/JCO.2008.19.3425. View

11.

Podratz J, Knight A, Ta L, Staff N, Gass J, Genelin K . Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis. 2010; 41(3):661-8. PMC: 3031677. DOI: 10.1016/j.nbd.2010.11.017. View

12.

Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C . Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain. 2012; 13(3):276-84. DOI: 10.1016/j.jpain.2011.11.009. View

13.

Zhu Y, Wu H, Wang P, Savas S, Woodrow J, Wish T . Dietary patterns and colorectal cancer recurrence and survival: a cohort study. BMJ Open. 2013; 3(2). PMC: 3586110. DOI: 10.1136/bmjopen-2012-002270. View

14.

Kuo T, McQueen A, Chen T, Wang J . Regulation of Glucose Homeostasis by Glucocorticoids. Adv Exp Med Biol. 2015; 872:99-126. PMC: 6185996. DOI: 10.1007/978-1-4939-2895-8_5. View

15.

Trauchburg A, Schwingshackl L, Hoffmann G . Association between Dietary Indices and Dietary Patterns and Mortality and Cancer Recurrence among Cancer Survivors: An Updated Systematic Review and Meta-Analysis of Cohort Studies. Nutrients. 2023; 15(14). PMC: 10385219. DOI: 10.3390/nu15143151. View

16.

Chiuve S, Fung T, Rimm E, Hu F, McCullough M, Wang M . Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012; 142(6):1009-18. PMC: 3738221. DOI: 10.3945/jn.111.157222. View

17.

Burden S, Stamataki Z, Hill J, Molasiotis A, Todd C . An exploration of food and the lived experience of individuals after treatment for colorectal cancer using a phenomenological approach. J Hum Nutr Diet. 2015; 29(2):137-45. DOI: 10.1111/jhn.12291. View

18.

Lipsitch M, Tchetgen Tchetgen E, Cohen T . Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010; 21(3):383-8. PMC: 3053408. DOI: 10.1097/EDE.0b013e3181d61eeb. View

19.

Brown J, Meyerhardt J, Yang S, Caan B . Postoperative chemotherapy relative dose intensity and overall survival in patients with colon cancer. Cancer Chemother Pharmacol. 2024; 94(3):461-465. PMC: 11417131. DOI: 10.1007/s00280-024-04665-5. View

20.

Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X . Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne). 2024; 14:1265372. PMC: 10803883. DOI: 10.3389/fendo.2023.1265372. View